Literature DB >> 2477329

Detection of interleukin 1 with human dermal fibroblasts.

H Loppnow1, H D Flad, I Dürrbaum, J Musehold, R Fetting, A J Ulmer, H Herzbeck, E Brandt.   

Abstract

A fibroblast proliferation assay was developed for the detection of interleukin 1 (IL 1). Proliferation was measured by thymidine incorporation and by staining of cellular proteins with crystal violet. Response of fibroblasts was optimal at cell numbers of 4,000 to 9,000 cells/culture and an incubation period of four days. Serum content of the culture medium, ranging from 1 to 10% fetal calf serum (FCS), enhanced the proliferative response in a concentration-dependent manner, while higher concentrations of FCS did not lead to further increase. Both detection methods were equally suitable for the measurement of IL 1 biological activity in purified and crude preparations. In contrast to the conventional thymocyte comitogenic assay, the fibroblasts in this assay did not proliferate in response to IL 2 or IL 6. Fibroblasts were weakly stimulated by recombinant (rec) tumor necrosis factor (rec TNF-alpha); they did, however, not proliferate in response to mitogens, lipopolysaccharide, rec granulocyte-macrophage colony stimulating factor (rec GM-CSF), macrophage-CSF, rec interferon-gamma, insulin or transferrin. The detection of IL 1 activity by crystal violet staining of human dermal fibroblasts was easier and faster than by measurement of thymidine incorporation of fibroblasts or mouse thymocytes; without loss of sensitivity, the sample capacity of the IL 1 assay could be enhanced, and the use of experimental animals was avoided.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2477329     DOI: 10.1016/S0171-2985(89)80023-3

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  13 in total

1.  FcR+ and FcR- monocytes differentially secrete monokines during pokeweed mitogen-induced T-cell-monocyte interactions.

Authors:  J Pryjma; B Mytar; H Loppnow; M Ernst; M Zembala; H D Flad
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS.

Authors:  H Loppnow; P Libby; M Freudenberg; J H Krauss; J Weckesser; H Mayer
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

3.  Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures.

Authors:  A J Ulmer; H Heine; W Feist; S Kusumoto; T Kusama; H Brade; U Schade; E T Rietschel; H D Flad
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Interleukin-1 gene expression in rabbit vascular tissue in vivo.

Authors:  S K Clinton; J C Fleet; H Loppnow; R N Salomon; B D Clark; J G Cannon; A R Shaw; C A Dinarello; P Libby
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

5.  Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component.

Authors:  A Sing; T Merlin; H P Knopf; P J Nielsen; H Loppnow; C Galanos; M A Freudenberg
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Glycosphingolipids from Sphingomonas paucimobilis induce monokine production in human mononuclear cells.

Authors:  C Krziwon; U Zähringer; K Kawahara; B Weidemann; S Kusumoto; E T Rietschel; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Immunomodulating properties of the antibiotic novobiocin in human monocytes.

Authors:  A Lührmann; J Thölke; I Behn; J Schumann; G Tiegs; S Hauschildt
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide.

Authors:  A J Ulmer; W Feist; H Heine; T Kirikae; F Kirikae; S Kusumoto; T Kusama; H Brade; U Schade; E T Rietschel
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro.

Authors:  B Schneider; A Thanhäuser; D Jocham; H Loppnow; E Vollmer; J Galle; H D Flad; A J Ulmer; A Böhle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures.

Authors:  B Weidemann; H Brade; E T Rietschel; R Dziarski; V Bazil; S Kusumoto; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.